Transcatheter edge-to-edge repair shows benefit for severe tricuspid regurgitation

NEW ORLEANS — Treatment of severe tricuspid regurgitation with transcatheter repair was safe, reduced severity of tricuspid regurgitation and led to improvements in quality of life at 1 year, according to results of the TRILUMINATE Pivotal trial.
“[The] TRILUMINATE Pivotal [trial] is a pioneering study as the first randomized clinical trial in this unique population of patients with

Related Keywords

Boston ,Massachusetts ,United States ,Canada ,Paul Sorajja ,Richard Smith ,Bykatie Kalvaitis ,Katie Kalvaitis ,Edwards Lifesciences ,American College Of Cardiology Scientific Session ,Wl Gore Associates ,Siemens ,Boston Scientific ,Medtronic ,Philips ,American College ,Cardiology Late Breaking Clinical ,Cardiology Scientific Session ,New Orleans ,Abbott Structural Heart ,Valve Science Center ,Minneapolis Heart Institute Foundation ,Structural Heart Disease ,Minneapolis Heart Institute ,Abbott Northwestern Hospital ,Cardiology Scientific ,Kansas City Cardiomyopathy Questionnaire ,New England Journal ,